Two studies found a statistically significant positive association between CRP and breast cancer risk for postmenopausal women (highest versus lowest tertile: HR 1.87, 95% CI: 1.17, 2.98 [31] and RR 2.42, 95% CI: 1.17, 5.00 [25]), but not for premenopausal women (HR 0.89, 95% CI: 0.37, 2.15 [31] and RR 0.74, 95% CI: 0.40, 1.37 [25], respectively). This evidence concerns the gene CRP and breast carcinoma.